Concepts (337)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hip Fractures | 36 | 2024 | 953 | 7.200 |
Why?
|
Norway | 67 | 2023 | 445 | 4.700 |
Why?
|
Emigrants and Immigrants | 12 | 2018 | 514 | 3.170 |
Why?
|
Vitamin D | 20 | 2020 | 3210 | 2.300 |
Why?
|
Osteoporosis | 13 | 2023 | 1575 | 1.640 |
Why?
|
Nutritional Status | 9 | 2020 | 1595 | 1.380 |
Why?
|
Iodine | 2 | 2020 | 285 | 1.180 |
Why?
|
Vitamin D Deficiency | 9 | 2020 | 1330 | 1.150 |
Why?
|
Dietary Supplements | 11 | 2020 | 3296 | 1.050 |
Why?
|
Fractures, Bone | 10 | 2019 | 1940 | 0.940 |
Why?
|
Body Mass Index | 22 | 2021 | 12665 | 0.920 |
Why?
|
Cardiovascular Diseases | 14 | 2023 | 15076 | 0.840 |
Why?
|
Emigration and Immigration | 3 | 2018 | 402 | 0.740 |
Why?
|
Potassium, Dietary | 2 | 2019 | 96 | 0.730 |
Why?
|
Arthroplasty, Replacement, Hip | 6 | 2023 | 1457 | 0.670 |
Why?
|
Vitamin B 12 | 3 | 2019 | 528 | 0.640 |
Why?
|
Risk Factors | 52 | 2023 | 72030 | 0.640 |
Why?
|
Prediabetic State | 2 | 2020 | 486 | 0.630 |
Why?
|
Vitamin B 6 | 1 | 2019 | 237 | 0.620 |
Why?
|
Deficiency Diseases | 1 | 2018 | 72 | 0.620 |
Why?
|
Vitamin A | 3 | 2015 | 621 | 0.610 |
Why?
|
Rickets | 1 | 2017 | 73 | 0.580 |
Why?
|
Bone Density Conservation Agents | 4 | 2023 | 771 | 0.570 |
Why?
|
Bone Density | 11 | 2020 | 3470 | 0.570 |
Why?
|
Sri Lanka | 6 | 2013 | 92 | 0.560 |
Why?
|
Mothers | 3 | 2013 | 2146 | 0.550 |
Why?
|
Elder Nutritional Physiological Phenomena | 1 | 2015 | 7 | 0.550 |
Why?
|
Sodium, Dietary | 1 | 2019 | 416 | 0.530 |
Why?
|
Obesity, Abdominal | 2 | 2016 | 360 | 0.530 |
Why?
|
Forearm Injuries | 2 | 2015 | 65 | 0.520 |
Why?
|
Nutrition Policy | 4 | 2020 | 486 | 0.520 |
Why?
|
Vitamin B Complex | 1 | 2017 | 290 | 0.510 |
Why?
|
Somalia | 7 | 2019 | 77 | 0.500 |
Why?
|
Male | 95 | 2023 | 349593 | 0.500 |
Why?
|
Urban Health | 1 | 2017 | 548 | 0.500 |
Why?
|
Infant Nutritional Physiological Phenomena | 1 | 2017 | 345 | 0.500 |
Why?
|
Female | 95 | 2024 | 379368 | 0.480 |
Why?
|
Cohort Studies | 26 | 2024 | 40437 | 0.480 |
Why?
|
Sex Factors | 12 | 2018 | 10403 | 0.470 |
Why?
|
Overweight | 6 | 2019 | 2362 | 0.450 |
Why?
|
Middle Aged | 73 | 2024 | 213217 | 0.440 |
Why?
|
Spinal Fractures | 1 | 2019 | 697 | 0.430 |
Why?
|
Marital Status | 1 | 2014 | 435 | 0.430 |
Why?
|
Seasons | 3 | 2014 | 1491 | 0.420 |
Why?
|
Proportional Hazards Models | 14 | 2022 | 12335 | 0.420 |
Why?
|
Calcium, Dietary | 4 | 2015 | 526 | 0.420 |
Why?
|
Cross-Sectional Studies | 24 | 2021 | 24745 | 0.420 |
Why?
|
Urban Population | 5 | 2019 | 2019 | 0.410 |
Why?
|
Osteoarthritis, Hip | 3 | 2023 | 410 | 0.410 |
Why?
|
Anthropometry | 2 | 2013 | 1351 | 0.410 |
Why?
|
Pakistan | 7 | 2011 | 293 | 0.400 |
Why?
|
Fatty Acids, Unsaturated | 2 | 2013 | 550 | 0.400 |
Why?
|
Humans | 116 | 2024 | 740505 | 0.400 |
Why?
|
Vitamins | 4 | 2015 | 1610 | 0.390 |
Why?
|
Aged | 53 | 2022 | 162955 | 0.380 |
Why?
|
Acculturation | 1 | 2012 | 182 | 0.380 |
Why?
|
Osteoporotic Fractures | 1 | 2015 | 400 | 0.370 |
Why?
|
Diet, Fat-Restricted | 1 | 2013 | 317 | 0.370 |
Why?
|
Body Weight | 5 | 2008 | 4667 | 0.370 |
Why?
|
Age Factors | 12 | 2018 | 18362 | 0.370 |
Why?
|
Adult | 58 | 2021 | 213729 | 0.370 |
Why?
|
Calcifediol | 3 | 2017 | 167 | 0.360 |
Why?
|
Muscle Strength | 1 | 2013 | 582 | 0.350 |
Why?
|
Incidence | 13 | 2022 | 20926 | 0.350 |
Why?
|
Nutritional Sciences | 1 | 2011 | 137 | 0.350 |
Why?
|
Waist Circumference | 4 | 2019 | 915 | 0.350 |
Why?
|
Health Status Disparities | 3 | 2016 | 1777 | 0.340 |
Why?
|
Rural Population | 4 | 2017 | 2193 | 0.330 |
Why?
|
Diet | 5 | 2024 | 7912 | 0.330 |
Why?
|
Infant Welfare | 1 | 2008 | 82 | 0.320 |
Why?
|
Turkey | 4 | 2011 | 235 | 0.320 |
Why?
|
Brazil | 3 | 2021 | 1259 | 0.320 |
Why?
|
Absorptiometry, Photon | 4 | 2008 | 1727 | 0.320 |
Why?
|
Urinalysis | 3 | 2019 | 370 | 0.310 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2021 | 11713 | 0.310 |
Why?
|
Prospective Studies | 22 | 2022 | 53075 | 0.300 |
Why?
|
Asia | 5 | 2017 | 604 | 0.300 |
Why?
|
Weight Gain | 4 | 2019 | 2287 | 0.300 |
Why?
|
Hip | 2 | 2008 | 257 | 0.300 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2021 | 3324 | 0.290 |
Why?
|
Prevalence | 14 | 2020 | 15177 | 0.280 |
Why?
|
Population Surveillance | 6 | 2018 | 2627 | 0.280 |
Why?
|
Radius Fractures | 2 | 2011 | 497 | 0.280 |
Why?
|
Risk Assessment | 9 | 2018 | 23309 | 0.280 |
Why?
|
Follow-Up Studies | 15 | 2020 | 38972 | 0.270 |
Why?
|
Sex Distribution | 4 | 2020 | 2297 | 0.260 |
Why?
|
Prostatic Neoplasms | 4 | 2018 | 11036 | 0.260 |
Why?
|
Obesity | 10 | 2021 | 12679 | 0.260 |
Why?
|
Weight Loss | 3 | 2008 | 2605 | 0.260 |
Why?
|
Fatty Acids | 1 | 2013 | 1805 | 0.250 |
Why?
|
Dietary Fats | 1 | 2013 | 2016 | 0.250 |
Why?
|
Life Style | 4 | 2013 | 3821 | 0.250 |
Why?
|
Hyperparathyroidism, Secondary | 2 | 2006 | 126 | 0.250 |
Why?
|
Body Composition | 1 | 2013 | 2399 | 0.240 |
Why?
|
Risk Reduction Behavior | 1 | 2010 | 1123 | 0.230 |
Why?
|
Randomized Controlled Trials as Topic | 3 | 2017 | 9813 | 0.230 |
Why?
|
Forearm | 4 | 2021 | 409 | 0.230 |
Why?
|
Cholesterol, HDL | 2 | 2009 | 1808 | 0.230 |
Why?
|
Exercise | 6 | 2022 | 5592 | 0.230 |
Why?
|
Young Adult | 19 | 2021 | 56363 | 0.230 |
Why?
|
Smoking | 9 | 2019 | 8964 | 0.220 |
Why?
|
Hormone Replacement Therapy | 1 | 2008 | 741 | 0.220 |
Why?
|
Breast Feeding | 2 | 2008 | 1335 | 0.220 |
Why?
|
Comorbidity | 6 | 2023 | 10369 | 0.210 |
Why?
|
Alcohol Drinking | 5 | 2019 | 3945 | 0.210 |
Why?
|
Femur | 1 | 2007 | 1297 | 0.200 |
Why?
|
Fish Products | 1 | 2020 | 29 | 0.190 |
Why?
|
Cod Liver Oil | 2 | 2015 | 9 | 0.190 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2004 | 386 | 0.190 |
Why?
|
Patient Education as Topic | 1 | 2011 | 2281 | 0.190 |
Why?
|
Parents | 1 | 2014 | 3371 | 0.190 |
Why?
|
Postmenopause | 4 | 2024 | 2457 | 0.190 |
Why?
|
Socioeconomic Factors | 5 | 2015 | 7733 | 0.180 |
Why?
|
Risk | 5 | 2015 | 9691 | 0.180 |
Why?
|
Chronic Disease | 2 | 2015 | 9151 | 0.180 |
Why?
|
Homocysteine | 2 | 2017 | 647 | 0.180 |
Why?
|
Registries | 7 | 2021 | 8043 | 0.180 |
Why?
|
Eggs | 1 | 2020 | 186 | 0.170 |
Why?
|
Educational Status | 5 | 2015 | 2516 | 0.170 |
Why?
|
Vietnam | 3 | 2011 | 408 | 0.170 |
Why?
|
Diet Surveys | 2 | 2020 | 1171 | 0.170 |
Why?
|
Pelvic Bones | 1 | 2021 | 265 | 0.170 |
Why?
|
Cold Temperature | 1 | 2022 | 776 | 0.160 |
Why?
|
Case-Control Studies | 6 | 2018 | 21718 | 0.160 |
Why?
|
Natriuresis | 1 | 2018 | 124 | 0.160 |
Why?
|
Folic Acid | 3 | 2017 | 1300 | 0.160 |
Why?
|
Aged, 80 and over | 14 | 2019 | 57769 | 0.160 |
Why?
|
Nutrition Assessment | 2 | 2019 | 722 | 0.160 |
Why?
|
Nutritional Requirements | 3 | 2019 | 284 | 0.160 |
Why?
|
Immunity | 2 | 2023 | 1011 | 0.160 |
Why?
|
Alcoholic Beverages | 1 | 2019 | 264 | 0.150 |
Why?
|
Seafood | 1 | 2020 | 381 | 0.150 |
Why?
|
Cholecalciferol | 2 | 2016 | 537 | 0.150 |
Why?
|
Linear Models | 5 | 2016 | 5950 | 0.150 |
Why?
|
Hypertension | 4 | 2017 | 8431 | 0.150 |
Why?
|
Dairy Products | 1 | 2020 | 498 | 0.150 |
Why?
|
Blood Banks | 1 | 2017 | 110 | 0.140 |
Why?
|
Myocardial Infarction | 2 | 2015 | 11673 | 0.140 |
Why?
|
Radius | 2 | 2011 | 422 | 0.140 |
Why?
|
Feeding Behavior | 4 | 2018 | 3184 | 0.140 |
Why?
|
Yugoslavia | 1 | 2015 | 22 | 0.140 |
Why?
|
Sodium Chloride, Dietary | 1 | 2018 | 281 | 0.140 |
Why?
|
25-Hydroxyvitamin D 2 | 1 | 2015 | 39 | 0.140 |
Why?
|
Databases, Factual | 2 | 2015 | 7702 | 0.130 |
Why?
|
Self Report | 3 | 2022 | 3523 | 0.130 |
Why?
|
Temperature | 1 | 2022 | 2203 | 0.130 |
Why?
|
Statistics, Nonparametric | 2 | 2020 | 2888 | 0.130 |
Why?
|
Double-Blind Method | 4 | 2019 | 11998 | 0.130 |
Why?
|
Infant | 6 | 2020 | 34968 | 0.130 |
Why?
|
alpha-Tocopherol | 1 | 2015 | 127 | 0.130 |
Why?
|
Potassium | 1 | 2019 | 1340 | 0.130 |
Why?
|
Iran | 2 | 2009 | 702 | 0.130 |
Why?
|
Job Description | 1 | 2014 | 59 | 0.120 |
Why?
|
Diabetes Mellitus | 5 | 2019 | 5706 | 0.120 |
Why?
|
Health Plan Implementation | 1 | 2017 | 351 | 0.120 |
Why?
|
Osteoarthritis | 1 | 2002 | 1026 | 0.120 |
Why?
|
Sodium | 1 | 2019 | 1625 | 0.120 |
Why?
|
Iron | 2 | 2016 | 1778 | 0.120 |
Why?
|
Vegetables | 2 | 2024 | 1179 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2014 | 110 | 0.110 |
Why?
|
Myanmar | 3 | 2017 | 45 | 0.110 |
Why?
|
Aluminum | 1 | 2013 | 151 | 0.110 |
Why?
|
Stroke | 1 | 2015 | 9906 | 0.110 |
Why?
|
Africa South of the Sahara | 1 | 2015 | 728 | 0.110 |
Why?
|
Body Fat Distribution | 1 | 2014 | 244 | 0.110 |
Why?
|
Cadmium | 1 | 2013 | 212 | 0.110 |
Why?
|
Carotenoids | 1 | 2015 | 624 | 0.110 |
Why?
|
Blood Proteins | 1 | 2017 | 1123 | 0.110 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2016 | 364 | 0.100 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 517 | 0.100 |
Why?
|
Language | 2 | 2012 | 1446 | 0.100 |
Why?
|
Cholesterol | 4 | 2019 | 2901 | 0.100 |
Why?
|
Body Weights and Measures | 1 | 2012 | 209 | 0.100 |
Why?
|
Calcium | 4 | 2012 | 5768 | 0.100 |
Why?
|
Child Health Services | 1 | 2017 | 670 | 0.100 |
Why?
|
Motor Activity | 2 | 2014 | 2719 | 0.100 |
Why?
|
Physical Fitness | 2 | 2009 | 733 | 0.100 |
Why?
|
Maternal-Child Health Centers | 1 | 2011 | 40 | 0.100 |
Why?
|
Nutrition Surveys | 2 | 2015 | 1651 | 0.090 |
Why?
|
Epidemiologic Studies | 2 | 2018 | 677 | 0.090 |
Why?
|
Adolescent | 12 | 2021 | 85503 | 0.090 |
Why?
|
Epidemiologic Research Design | 1 | 2014 | 368 | 0.090 |
Why?
|
Ulna | 1 | 2011 | 133 | 0.090 |
Why?
|
Longitudinal Studies | 3 | 2022 | 13889 | 0.090 |
Why?
|
Drug Utilization | 2 | 2014 | 1184 | 0.090 |
Why?
|
Magnesium | 1 | 2013 | 813 | 0.090 |
Why?
|
Ulna Fractures | 1 | 2011 | 125 | 0.090 |
Why?
|
Endpoint Determination | 1 | 2012 | 600 | 0.090 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 1366 | 0.090 |
Why?
|
Calibration | 2 | 2013 | 817 | 0.090 |
Why?
|
Ferritins | 2 | 2016 | 592 | 0.090 |
Why?
|
Blood Glucose | 3 | 2019 | 6241 | 0.090 |
Why?
|
Placebos | 1 | 2013 | 1679 | 0.090 |
Why?
|
Diagnostic Self Evaluation | 1 | 2011 | 231 | 0.080 |
Why?
|
Minority Groups | 2 | 2013 | 1198 | 0.080 |
Why?
|
Amyotrophic Lateral Sclerosis | 1 | 2019 | 1435 | 0.080 |
Why?
|
Cross-Cultural Comparison | 1 | 2012 | 649 | 0.080 |
Why?
|
Lead | 1 | 2013 | 851 | 0.080 |
Why?
|
Drug Prescriptions | 2 | 2015 | 1640 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2013 | 821 | 0.080 |
Why?
|
Mass Screening | 2 | 2017 | 5270 | 0.080 |
Why?
|
Arthritis, Rheumatoid | 1 | 2023 | 3689 | 0.080 |
Why?
|
Fruit | 1 | 2013 | 1140 | 0.080 |
Why?
|
Child | 8 | 2021 | 77137 | 0.070 |
Why?
|
Drug Costs | 1 | 2015 | 1115 | 0.070 |
Why?
|
Time Factors | 6 | 2018 | 40111 | 0.070 |
Why?
|
Multiple Sclerosis | 1 | 2021 | 3072 | 0.070 |
Why?
|
Headache | 1 | 2014 | 1200 | 0.070 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4940 | 0.070 |
Why?
|
Health Status | 2 | 2011 | 4014 | 0.070 |
Why?
|
Hemoglobins | 2 | 2016 | 1534 | 0.070 |
Why?
|
Regression Analysis | 2 | 2014 | 6455 | 0.070 |
Why?
|
Insulin Resistance | 1 | 2019 | 3858 | 0.070 |
Why?
|
Growth | 1 | 2007 | 377 | 0.070 |
Why?
|
Cause of Death | 1 | 2016 | 3564 | 0.070 |
Why?
|
Body Height | 3 | 2008 | 1577 | 0.070 |
Why?
|
Reference Values | 2 | 2015 | 4989 | 0.070 |
Why?
|
Logistic Models | 4 | 2015 | 13413 | 0.070 |
Why?
|
Health Surveys | 2 | 2013 | 4024 | 0.060 |
Why?
|
Diphosphonates | 2 | 2023 | 624 | 0.060 |
Why?
|
Acute Disease | 1 | 2015 | 7137 | 0.060 |
Why?
|
Health Behavior | 1 | 2016 | 2624 | 0.060 |
Why?
|
Patient Compliance | 1 | 2015 | 2681 | 0.060 |
Why?
|
Child, Preschool | 4 | 2020 | 40847 | 0.060 |
Why?
|
Dietary Services | 1 | 2004 | 17 | 0.060 |
Why?
|
Canada | 1 | 2010 | 2024 | 0.060 |
Why?
|
Survival Rate | 2 | 2016 | 12782 | 0.060 |
Why?
|
Recurrence | 2 | 2012 | 8317 | 0.060 |
Why?
|
Osteoarthritis, Knee | 1 | 2014 | 1218 | 0.060 |
Why?
|
Reference Standards | 1 | 2007 | 1019 | 0.060 |
Why?
|
Data Interpretation, Statistical | 1 | 2014 | 2715 | 0.060 |
Why?
|
Age Distribution | 1 | 2010 | 2906 | 0.060 |
Why?
|
Middle East | 2 | 2016 | 219 | 0.060 |
Why?
|
Health Status Indicators | 1 | 2009 | 969 | 0.060 |
Why?
|
Fish Oils | 1 | 2007 | 469 | 0.060 |
Why?
|
Sensitivity and Specificity | 2 | 2017 | 14769 | 0.060 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2014 | 1458 | 0.060 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2017 | 3911 | 0.050 |
Why?
|
Bone Resorption | 1 | 2006 | 726 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2017 | 15524 | 0.050 |
Why?
|
Infant, Newborn | 3 | 2020 | 25497 | 0.050 |
Why?
|
Prosthesis-Related Infections | 1 | 2007 | 538 | 0.050 |
Why?
|
Work | 1 | 2002 | 191 | 0.050 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2002 | 404 | 0.050 |
Why?
|
Mortality | 1 | 2012 | 2850 | 0.050 |
Why?
|
Hip Prosthesis | 1 | 2007 | 918 | 0.050 |
Why?
|
Public Health | 1 | 2013 | 2587 | 0.050 |
Why?
|
Prosthesis Design | 1 | 2007 | 2113 | 0.050 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2002 | 705 | 0.040 |
Why?
|
Spouses | 1 | 2002 | 283 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 28979 | 0.040 |
Why?
|
Blood Pressure | 4 | 2019 | 8573 | 0.040 |
Why?
|
Osteogenesis | 1 | 2006 | 1291 | 0.040 |
Why?
|
Phantoms, Imaging | 1 | 2007 | 2511 | 0.040 |
Why?
|
Physical Exertion | 1 | 2002 | 695 | 0.040 |
Why?
|
Food, Fortified | 1 | 2020 | 191 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2009 | 15070 | 0.040 |
Why?
|
Arteriosclerosis | 1 | 2002 | 1092 | 0.040 |
Why?
|
Secondary Prevention | 2 | 2015 | 1516 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2013 | 19849 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 2004 | 1799 | 0.040 |
Why?
|
Coronary Disease | 2 | 2002 | 6075 | 0.040 |
Why?
|
Guidelines as Topic | 2 | 2020 | 1410 | 0.040 |
Why?
|
New Zealand | 1 | 2017 | 355 | 0.040 |
Why?
|
Reoperation | 1 | 2007 | 4195 | 0.040 |
Why?
|
Patient Discharge | 1 | 2010 | 3291 | 0.040 |
Why?
|
Practice Guidelines as Topic | 1 | 2014 | 7284 | 0.040 |
Why?
|
Blood Specimen Collection | 1 | 2017 | 250 | 0.030 |
Why?
|
Transferrin | 1 | 2016 | 295 | 0.030 |
Why?
|
Aging | 1 | 2013 | 8621 | 0.030 |
Why?
|
Life Expectancy | 1 | 2021 | 1209 | 0.030 |
Why?
|
Finland | 1 | 2015 | 604 | 0.030 |
Why?
|
United States | 2 | 2019 | 69657 | 0.030 |
Why?
|
Odds Ratio | 2 | 2018 | 9852 | 0.030 |
Why?
|
Trace Elements | 1 | 2015 | 198 | 0.030 |
Why?
|
Teriparatide | 1 | 2015 | 225 | 0.030 |
Why?
|
Denmark | 1 | 2015 | 730 | 0.030 |
Why?
|
Neoplasms | 2 | 2017 | 21558 | 0.030 |
Why?
|
Pregnancy | 2 | 2020 | 29039 | 0.030 |
Why?
|
Urbanization | 1 | 2013 | 102 | 0.030 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10953 | 0.030 |
Why?
|
Chromatography, Liquid | 1 | 2015 | 985 | 0.030 |
Why?
|
Heart Rate | 1 | 2022 | 4090 | 0.020 |
Why?
|
Intention to Treat Analysis | 1 | 2012 | 423 | 0.020 |
Why?
|
Europe | 1 | 2017 | 3336 | 0.020 |
Why?
|
Metabolic Diseases | 1 | 2017 | 658 | 0.020 |
Why?
|
Meta-Analysis as Topic | 1 | 2015 | 1339 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2017 | 852 | 0.020 |
Why?
|
Endothelium, Vascular | 1 | 2002 | 4487 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1454 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2721 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2015 | 1158 | 0.020 |
Why?
|
Animals | 2 | 2024 | 168756 | 0.020 |
Why?
|
Hypolipidemic Agents | 1 | 2013 | 606 | 0.020 |
Why?
|
Drug Utilization Review | 1 | 2009 | 245 | 0.020 |
Why?
|
Survival Analysis | 1 | 2021 | 10255 | 0.020 |
Why?
|
Occupational Health | 1 | 2014 | 808 | 0.020 |
Why?
|
Oxidoreductases Acting on CH-NH Group Donors | 1 | 2007 | 62 | 0.020 |
Why?
|
Prostate | 1 | 2015 | 1757 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2019 | 3612 | 0.020 |
Why?
|
Tablets | 1 | 2007 | 149 | 0.020 |
Why?
|
Acid Phosphatase | 1 | 2006 | 141 | 0.020 |
Why?
|
Capsules | 1 | 2007 | 200 | 0.020 |
Why?
|
Biological Availability | 1 | 2007 | 391 | 0.020 |
Why?
|
Social Class | 1 | 2015 | 1976 | 0.020 |
Why?
|
Osteocalcin | 1 | 2006 | 273 | 0.020 |
Why?
|
Glucocorticoids | 1 | 2015 | 2103 | 0.020 |
Why?
|
Asthma | 1 | 2004 | 5953 | 0.020 |
Why?
|
C-Reactive Protein | 1 | 2016 | 3752 | 0.020 |
Why?
|
Pain Measurement | 1 | 2014 | 3422 | 0.020 |
Why?
|
Analysis of Variance | 2 | 2004 | 6372 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2006 | 864 | 0.010 |
Why?
|
Eicosanoic Acids | 1 | 2002 | 17 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2014 | 6530 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2014 | 62758 | 0.010 |
Why?
|
Drug Therapy, Combination | 1 | 2012 | 6481 | 0.010 |
Why?
|
Isoenzymes | 1 | 2006 | 1721 | 0.010 |
Why?
|
Sampling Studies | 1 | 2002 | 624 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2015 | 10995 | 0.010 |
Why?
|
China | 1 | 2006 | 2228 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2014 | 12244 | 0.010 |
Why?
|
Fasting | 1 | 2006 | 1590 | 0.010 |
Why?
|
Residence Characteristics | 1 | 2009 | 2041 | 0.010 |
Why?
|
Administration, Oral | 1 | 2007 | 3912 | 0.010 |
Why?
|
Computer Simulation | 1 | 2013 | 6253 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2004 | 2976 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2013 | 4375 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2018 | 76733 | 0.010 |
Why?
|
Probability | 1 | 2002 | 2502 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1166 | 0.010 |
Why?
|
Sex Characteristics | 1 | 2006 | 2585 | 0.010 |
Why?
|
Chi-Square Distribution | 1 | 2002 | 3507 | 0.010 |
Why?
|
Data Collection | 1 | 2004 | 3348 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2009 | 3139 | 0.010 |
Why?
|
Bone and Bones | 1 | 2004 | 2572 | 0.010 |
Why?
|
Stress, Psychological | 1 | 2008 | 4213 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2007 | 15519 | 0.000 |
Why?
|
Concepts
(337)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(10)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_